RxDoctor Payments DataLook up a doctor →

Amanda Humbers

Nurse Practitioner · Farmington, MONPI 1720421514

Payments from drug & device makers

$19,282in general payments, 2019–2025

Across 1,166 payments — averaging $16.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • UCB, Inc.$2K
  • Novartis$1K
  • AstraZeneca$1K
  • SK Life Science, Inc.$1K
  • AbbVie$1K
  • Teva Pharmaceuticals USA, Inc.$824
  • plus $12K from 53 others

What the payments were for

  • Food & beverage$19,204100%
  • Education$780%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
UCB, Inc.83$1,864
Novartis102$1,372
AstraZeneca(2 entities)47$1,100
SK Life Science, Inc.71$1,085
AbbVie(2 entities)90$1,029
Teva Pharmaceuticals USA, Inc.54$824
Neurocrine Biosciences, Inc.33$739
EMD Serono, Inc.40$719
Amgen(2 entities)47$687
Pfizer82$683
Argenx US, Inc.34$665
Acadia Pharmaceuticals Inc31$649
Bristol Myers Squibb39$644
Lilly USA, LLC44$584
Biohaven Pharmaceutical Holding Company Ltd.39$528
Biohaven Pharmaceuticals, Inc.44$527
Amneal Pharmaceuticals LLC41$524
Sunovion Pharmaceuticals Inc.21$372
Jazz Pharmaceuticals Inc.16$345
Biogen17$342
Sanofi13$323
Genentech USA, Inc.17$287
Neurelis, Inc.12$276
Livanova USA, Inc.5$259
Lundbeck LLC13$253
Harmony Biosciences LLC7$242
Ipsen Biopharmaceuticals, Inc10$226
TG Therapeutics, Inc.8$207
Supernus Pharmaceuticals, Inc.12$197
Banner Life Sciences, LLC9$178
Takeda Pharmaceuticals U.S.A., Inc.9$161
Upsher-smith Laboratories LLC7$133
Alnylam Pharmaceuticals Inc.6$115
Aquestive Therapeutics, Inc.6$102
Ironshore Pharmaceuticals Inc.5$96
Scilex Pharmaceuticals Inc.5$93
Vanda Pharmaceuticals Inc.3$76
Nevro Corp.4$68
Otsuka America Pharmaceutical, Inc.4$67
Corium, LLC4$57
Catalyst Pharmaceuticals, Inc.3$57
Avanir Pharmaceuticals, Inc.3$47
MDD US Operations, LLC2$45
Cycle Pharmaceuticals Inc2$45
Adamas Pharmaceuticals, Inc.2$42
E.r. Squibb & Sons, L.L.C.2$40
CSL Behring2$39
Johnson & Johnson(2 entities)2$39
Eisai Inc.2$34
Axsome Therapeutics, Inc.1$26
NS Pharma, Inc.1$25
Sumitomo Pharma America, Inc.3$24
Tanabe Pharma America, Inc.1$23
Immedica Pharma US, Inc.1$19
GRT US Holding, Inc.1$17
W. L. Gore & Associates, Inc.1$15
Kyowa Kirin, Inc.1$15
Avion Pharmaceuticals1$15
Arbor Pharmaceuticals, Inc.1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,282 in reported general payments places this provider in the 95th percentile of 1,898 nurse practitioner providers in Missouri.

See all nurse practitioner providers in Missouri

Medicare billing

Part B allowed, 2024
$57,677
Medicare patients
295
Services billed
589

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Nurtec OdtRimegepant Sulfate169$222,659
UbrelvyUbrogepant100$109,785
Aimovig AutoinjectorErenumab-Aooe99$88,998
Emgality PenGalcanezumab-Gnlm71$61,485
XcopriCenobamate33$40,730
QuliptaAtogepant25$33,782
AptiomEslicarbazepine Acetate12$27,440
Ajovy AutoinjectorFremanezumab-Vfrm35$24,840
Dalfampridine ErDalfampridine22$15,746
Levetiracetam235$8,314
Pyridostigmine Bromide ErPyridostigmine Bromide12$5,900
Lacosamide46$5,545
Oxcarbazepine62$5,083
CarbatrolCarbamazepine17$4,793
Divalproex Sodium ErDivalproex Sodium81$4,660

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerNurtec Odt$683$222,659169 claims
AbbVieUbrelvy, Qulipta$1,029$143,567125 claims
SK Life Science, Inc.Xcopri$1,085$40,73033 claims
Sunovion Pharmaceuticals Inc.Aptiom$372$27,44012 claims
Upsher-smith Laboratories LLCTopiramate$133$2,214131 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,898 nurse practitioner providers in Missouri.

Other nurse practitioner in Farmington

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →